Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) Return on Sales (2024 - 2025)

Historic Return on Sales for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to 1.95%.

  • Abivax's Return on Sales rose 36800.0% to 1.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.61%, marking a year-over-year increase of 53400.0%. This contributed to the annual value of 14.16% for FY2024, which is 178100.0% up from last year.
  • Latest data reveals that Abivax reported Return on Sales of 1.95% as of Q3 2025, which was up 36800.0% from 9.23% recorded in Q2 2025.
  • Abivax's 5-year Return on Sales high stood at 1.31% for Q4 2024, and its period low was 9.23% during Q2 2025.